Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PF-04691502 |
| Trade Name | |
| Synonyms | PF04691502|PF 04691502 |
| Drug Descriptions |
PF-04691502 is a PI3K/mTOR dual inhibitor with broad antitumor activity (PMID: 21750219, PMID: 31822716). |
| DrugClasses | mTOR Inhibitor 51 PI3K Inhibitor (Pan) 42 |
| CAS Registry Number | 1013101-36-4 |
| NCIT ID | C84837 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| H3B-5942 + PF-04691502 | H3B-5942 PF-04691502 | 0 | 0 |
| Mirdametinib + PF-04691502 | Mirdametinib PF-04691502 | 0 | 0 |
| Palbociclib + PF-04691502 | PF-04691502 Palbociclib | 2 | 0 |
| PF-04691502 | PF-04691502 | 6 | 0 |
| PF-04691502 + Quizartinib | PF-04691502 Quizartinib | 1 | 0 |
| PF-04691502 + SCH772984 | PF-04691502 SCH772984 | 0 | 0 |